Get the Stockscreener App
10.55
4.61%
-0.51
After Hours:
11.08
0.53
+5.02%
Aligos Therapeutics Inc stock is traded at $10.55, with a volume of 61,168.
It is down -4.61% in the last 24 hours and up +31.22% over the past month.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
See More
Previous Close:
$11.06
Open:
$11.06
24h Volume:
61,168
Relative Volume:
0.63
Market Cap:
$56.46M
Revenue:
$7.97M
Net Income/Loss:
$-75.74M
P/E Ratio:
-0.4344
EPS:
-24.2853
Net Cash Flow:
$-85.33M
1W Performance:
+3.43%
1M Performance:
+31.22%
6M Performance:
-37.05%
1Y Performance:
-19.83%
1-Day Range:
$10.07
$11.19
1-Week Range:
$9.92
$11.70
52-Week Range:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Name
Aligos Therapeutics Inc
Sector
Industry
Phone
(800) 466-6059
Address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Compare ALGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
10.55 | 76.88M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
| Jan-06-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-23-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-07-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-06-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-09-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Resumed | Piper Sandler | Overweight |
| Nov-10-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-10-20 | Initiated | JP Morgan | Overweight |
| Nov-10-20 | Initiated | Jefferies | Buy |
| Nov-10-20 | Initiated | Piper Sandler | Overweight |
View All
Aligos Therapeutics Inc Stock (ALGS) Latest News
Best data tools to analyze Aligos Therapeutics Inc. stockMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser
Short interest data insights for Aligos Therapeutics Inc.July 2025 Levels & Verified Chart Pattern Signals - Newser
Aligos Therapeutics Inc.’s volatility index tracking explainedTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Evaluating Aligos Therapeutics Inc. with trendline analysisJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Can you recover from losses in Aligos Therapeutics Inc.July 2025 Intraday Action & Fast Gain Stock Tips - Newser
Candlestick signals on Aligos Therapeutics Inc. stock today2025 Momentum Check & Daily Stock Momentum Reports - Newser
What’s next for Aligos Therapeutics Inc. stock priceJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - Newser
Heatmap analysis for Aligos Therapeutics Inc. and competitorsIndex Update & Low Volatility Stock Recommendations - Newser
Aligos Therapeutics Inc. stock momentum explainedTrade Ideas & Intraday High Probability Setup Alerts - Newser
Does Aligos Therapeutics Inc. show high probability of reboundJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Backtesting results for Aligos Therapeutics Inc. trading strategiesJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attention2025 Market Overview & High Accuracy Swing Entry Alerts - Newser
Is Aligos Therapeutics Inc. forming a bottoming base2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Will Aligos Therapeutics Inc. continue its uptrendTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
Will Aligos Therapeutics Inc. stock go up soonTrade Risk Report & Verified Technical Signals - Newser
Intraday pattern recognizer results for Aligos Therapeutics Inc.July 2025 Highlights & Verified Entry Point Signals - Newser
Volatility clustering patterns for Aligos Therapeutics Inc.Weekly Investment Report & AI Optimized Trade Strategies - Newser
Published on: 2025-08-29 14:33:52 - Newser
Can volume confirm reversal in Aligos Therapeutics Inc.Weekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Is Aligos Therapeutics Inc. affected by consumer sentimentJuly 2025 Closing Moves & Expert Curated Trade Ideas - sundaytimes.kr
Is Aligos Therapeutics Inc. meeting your algorithmic filter criteria2025 Buyback Activity & Expert Curated Trade Setup Alerts - Newser
Published on: 2025-08-29 05:22:02 - Newser
Combining price and volume data for Aligos Therapeutics Inc.Profit Target & Fast Moving Trade Plans - Newser
Reversal indicators forming on Aligos Therapeutics Inc. stockJuly 2025 Summary & Expert Approved Trade Ideas - Newser
Aligos Therapeutics Inc Stock (ALGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):